Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
NCT00729313
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
111
Enrollment
INDUSTRY
Sponsor class
Conditions
Digestive Fistulae
Interventions
DRUG:
Lanreotide microparticles
DRUG:
Placebo
Sponsor
Ipsen